NM_000363.5:c.626A>C
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PM5PP3_Moderate
The NM_000363.5(TNNI3):c.626A>C(p.Glu209Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E209K) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000363.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:5Uncertain:1
A variant of uncertain significance has been identified in the TNNI3 gene. The E209A variant has been reported as a possibly deleterious variant in at least 5 unrelated probands with cardiomyopathy (van den Wijngaard et al., 2011); however, familial segregation information and in vitro functional studies were not included. Nevertheless, the E209A variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution occurs at a position that is conserved in mammals. Finally, in silico analysis predicts this variant is probably damaging to the protein structure/function. -
- -
- -
- -
- -
- -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 209 of the TNNI3 protein (p.Glu209Ala). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with TNNI3-related conditions (PMID: 21533915, 27532257). ClinVar contains an entry for this variant (Variation ID: 181595). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.E209A variant (also known as c.626A>C), located in coding exon 8 of the TNNI3 gene, results from an A to C substitution at nucleotide position 626. The glutamic acid at codon 209 is replaced by alanine, an amino acid with dissimilar properties. This alteration has been reported in a subject with features of restrictive cardiomyopathy and hypertrophic cardiomyopathy (HCM) cohorts (van den Wijngaard A et al. Neth Heart J, 2011 Aug;19:344-51; Walsh R et al. Genet Med, 2017 02;19:192-203; Marschall C et al. Cardiovasc Diagn Ther, 2019 Oct;9:S292-S298; van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at